About
Profile
Sarepta Therapeutics is a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases.
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
SRPT
Shares tumbled 18% after posting a steep loss in the first-quarter, and slashing its full-year net product revenue forecast to a range of $2.30 billion to $2.60 billion. Analysts were looking for that metric to be between $2.90 billion and $3.10 billion.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Sarepta Therapeutics GAAP EPS of -$0.46 beats by $0.80, revenue of $331.8M beats by $45.03M
- Sarepta Therapeutics Q3 2023 Earnings Preview
- Biggest stock movers today: Caterpillar, Arista Networks, BP, Pinterest and more
- Sarepta in selloff after late-stage setback for Duchenne candidate
- 5 stocks to watch on Tuesday: Sarepta Therapeutics, Pfizer, AMD and more
- Sarepta Phase 3 study for DMD drug fails to meet primary endpoint
- Mizuho doesn't see Sarepta price decline connected to EMBARK study
- Sarepta Therapeutics Non-GAAP EPS of -$0.85 beats by $0.15, revenue of $261.2M beats by $5.36M
- Sarepta Therapeutics Q2 2023 Earnings Preview
- Acumen, BridgeBio, Arcus among BTIG's top healthcare picks for 2H 2023
- Catalyst Watch: CPI, major bank earnings, Amazon Prime Day and CAVA ratings
- Sarepta raises $102M from selling priority review voucher
- Sarepta down 9% as Duchenne treatment gets narrow population approval
- Sarepta Duchenne treatment wins FDA nod, but with smaller population (update)
- Regenxbio, UPenn file second patent suit against Sarepta over DMD therapy
- Catalyst watch: C3.ai and Salesforce earnings, Knife River debut, Kenvue ratings & Faraday Future event
- Hot Stocks: ANF, URBN and PANW rise on earnings; A, XPEV fall on weak outlooks; OCGN slides
- Sarepta says FDA needs more time to review muscular dystrophy drug
- Billions of dollars at stake as FDA shortcut allows half-proven drugs - report
- Argenx, Blueprint Medicines, Sarepta likely M&A targets - analyst
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| October 27, 2021 | - / -1.83 | - / 171.36M | |
| August 4, 2021 | -1.02 / -1.3 | 164.09M / 167.07M | |
| May 5, 2021 | -2.1 / -1.83 | 146.93M / 145.81M |
Beat! |
| March 1, 2021 | -2.4 / -1.8 | 145.14M / 150.38M | |
| November 5, 2020 | -2.5 / -1.71 | 143.92M / 137.76M |
Beat! |
| August 5, 2020 | -1.93 / -1.72 | 137.36M / 116.29M |
Beat! |
| May 6, 2020 | -0.23 / -1.92 | 113.67M / 116.49M | |
| February 26, 2020 | -3.16 / -1.81 | 100.11M / 98.8M |
Beat! |
| November 7, 2019 | -1.7 / -1.35 | 99.04M / 98.48M |
Beat! |
| August 7, 2019 | -3.74 / -1.07 | 94.67M / 91.05M |
Beat! |
| May 8, 2019 | -1.07 / -1.61 | 87.01M / 86.6M |
Beat! |
| February 27, 2019 | -2.05 / -1.02 | 84.42M / 84.92M | |
| October 24, 2018 | -1.15 / -0.78 | 78.49M / 78.75M | |
| August 8, 2018 | -1.67 / -0.84 | 73.53M / 71.4M |
Beat! |
| May 3, 2018 | -0.55 / -0.32 | 64.6M / 65.09M | |
| February 26, 2018 | - / -0.32 | - / 55.57M | |
| October 25, 2017 | -0.76 / -0.85 | 45.95M / 40.77M |
Beat! |
| July 19, 2017 | -0.46 / -0.77 | 35.01M / 22.38M |
Beat! |
| April 27, 2017 | -0.71 / -0.81 | 16.34M / - |
Beat! |
| February 28, 2017 | -0.71 / -0.45 | 5.42M / 46.83M | |
| October 27, 2016 | -1.18 / -0.52 | - / 3.08M |
| Date | Price | Open | High | Low | Vol | Change | |||
|---|---|---|---|---|---|---|---|---|---|
| Jun 17 | 21.56 | 21.16 |
22.98
|
20.51
|
14.5M | 2.96% | |||
| Jun 16 | 20.94 | 21.26 |
21.55
|
18.3
|
44.2M | -42.12% | |||
| Jun 13 | 36.18 | 37.05 |
38.09
|
35.77
|
3.2M | -3.03% | |||
| Jun 12 | 37.31 | 37.6 |
37.84
|
36.8
|
3.2M | -1.32% | |||
| Jun 11 | 37.81 | 39.31 |
39.64
|
37.76
|
2.4M | -3.22% | |||
| Jun 10 | 39.07 | 40 |
40.9
|
38.95
|
3.4M | -1.61% | |||
| Jun 9 | 39.71 | 43.79 |
43.92
|
39.41
|
5.6M | -7.67% | |||
| Jun 6 | 43.01 | 40.45 |
43.54
|
40.45
|
4.9M | 9.69% | |||
| Jun 5 | 39.21 | 39.54 |
40.49
|
37.91
|
2.9M | -0.83% | |||
| Jun 4 | 39.54 | 39.05 |
40.28
|
38.63
|
2.3M | 1.72% | |||
| Jun 3 | 38.87 | 37.72 |
39.12
|
37.15
|
2.2M | 2.99% | |||
| Jun 2 | 37.74 | 37.85 |
39.01
|
37.07
|
2.2M | 0.37% | |||
| May 30 | 37.6 | 38.05 |
38.15
|
36.96
|
3.1M | -2.62% | |||
| May 29 | 38.61 | 37.54 |
38.79
|
36.98
|
2.5M | 3.71% | |||
| May 28 | 37.23 | 38.33 |
39.35
|
36.89
|
3.3M | -2.92% | |||
| May 27 | 38.35 | 38.34 |
39.56
|
37.88
|
4.2M | 1.19% | |||
| May 23 | 37.9 | 38 |
38.41
|
37.64
|
2.1M | -2.29% | |||
| May 22 | 38.79 | 39.67 |
40.1
|
38.69
|
3.7M | -3.15% | |||
| May 21 | 40.05 | 41.01 |
44.14
|
39.96
|
8.4M | 0.15% | |||
| May 20 | 39.99 | 38.02 |
40.7
|
37.15
|
4.9M | 5.40% | |||
| May 19 | 37.94 | 35.99 |
38.36
|
35.85
|
3.7M | 4.14% | |||
| May 16 | 36.43 | 35.64 |
36.72
|
35.25
|
4.1M | 3.29% | |||
| May 15 | 35.27 | 35.7 |
35.7
|
34.1
|
3.9M | -1.32% | |||
| May 14 | 35.74 | 36.25 |
37.42
|
35.56
|
5.2M | -1.27% | |||
| May 13 | 36.2 | 36.57 |
37.32
|
34.9
|
5.7M | -0.47% | |||
| May 12 | 36.37 | 37.7 |
39.21
|
36.21
|
8.4M | 0.28% | |||
| May 9 | 36.27 | 37.32 |
39.66
|
35.93
|
6.6M | -0.68% | |||
| May 8 | 36.52 | 37.26 |
38.03
|
35.46
|
9.2M | -0.54% | |||
| May 7 | 36.72 | 39.99 |
40
|
36.58
|
20.8M | -21.45% | |||
| May 6 | 46.75 | 62.92 |
63.92
|
46.52
|
15.8M | -26.56% | |||
| May 5 | 63.66 | 63.41 |
64.8
|
63.12
|
2.1M | 0.24% | |||
| May 2 | 63.51 | 63.5 |
64.3
|
63.02
|
1.4M | 1.16% | |||
| May 1 | 62.78 | 62.45 |
64
|
60.53
|
1.4M | 0.61% | |||
| Apr 30 | 62.4 | 59.98 |
62.51
|
59.62
|
1.6M | 2.55% | |||
| Apr 29 | 60.85 | 61.37 |
62.13
|
60.55
|
2.0M | -1.07% | |||
| Apr 28 | 61.51 | 60.59 |
62.47
|
60.18
|
1.2M | 1.77% | |||
| Apr 25 | 60.44 | 61.68 |
61.92
|
59.96
|
1.3M | -2.14% | |||
| Apr 24 | 61.76 | 59.63 |
61.91
|
58.76
|
1.6M | 3.82% | |||
| Apr 23 | 59.49 | 61.65 |
62.78
|
59.06
|
1.9M | 0.30% | |||
| Apr 22 | 59.31 | 55.66 |
59.33
|
55.52
|
2.5M | 7.39% | |||
| Apr 21 | 55.23 | 53.4 |
56.11
|
52.8
|
1.5M | 2.68% | |||
| Apr 17 | 53.79 | 53.7 |
55.49
|
53.56
|
1.9M | -0.28% | |||
| Apr 16 | 53.94 | 54.59 |
55.01
|
53.02
|
1.4M | -0.88% | |||
| Apr 15 | 54.42 | 54.09 |
56.34
|
53.23
|
2.2M | -0.38% | |||
| Apr 14 | 54.63 | 53.34 |
54.64
|
51.39
|
2.3M | 7.05% | |||
| Apr 11 | 51.03 | 51.22 |
51.8
|
49.08
|
4.0M | 1.43% | |||
| Apr 10 | 50.31 | 53.34 |
54.47
|
49.86
|
2.9M | -9.6% | |||
| Apr 9 | 55.65 | 48.55 |
57.7
|
48.01
|
4.3M | 12.88% | |||
| Apr 8 | 49.3 | 53.99 |
55.36
|
48.94
|
3.6M | -5.92% | |||
| Apr 7 | 52.4 | 51.59 |
55.17
|
50.61
|
4.2M | -3.73% | |||
| Apr 4 | 54.43 | 59.22 |
59.45
|
54.26
|
4.6M | -7.13% | |||
| Apr 3 | 58.61 | 57.22 |
60.24
|
57.14
|
3.8M | -6.18% | |||
| Apr 2 | 62.47 | 61.69 |
64.22
|
60.7
|
3.8M | 0.90% | |||
| Apr 1 | 61.91 | 64.37 |
65.69
|
61.53
|
3.5M | -2.99% | |||
| Mar 31 | 63.82 | 65.9 |
67.47
|
62.5
|
4.6M | -9.36% | |||
| Mar 28 | 70.41 | 71.88 |
72.05
|
69.81
|
985K | -1.95% | |||
| Mar 27 | 71.81 | 72.98 |
73.95
|
71.25
|
1.4M | -1.47% | |||
| Mar 26 | 72.88 | 73.88 |
74.4
|
70.91
|
1.4M | -0.99% | |||
| Mar 25 | 73.61 | 76.13 |
76.26
|
72.17
|
1.3M | -3.56% | |||
| Mar 24 | 76.33 | 74.67 |
76.67
|
74.44
|
1.9M | 0% | |||